Evidence map›Paper›PMID 41165512›Full record

ArticleAdvanced healthcare materials2026

Transformative Bioactive Wear Resistant Ti

Cecil Cherian Lukose, Ioannis Anestopoulos, Iraklis-Stavros Panagiotidis, Guillaume Zoppi, Anna M Black, Lynn G Dover, Leon Bowen, Ángel Serrano-Aroca, Lorenzo Mendola, Davide Morrone and 2 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Transformative Bioactive Wear Resistant TiAdvanced healthcare materials · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Cecil Cherian LukoseFaculty of Engineering and Environment, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK.
Ioannis AnestopoulosDepartment of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 1683, Cyprus.
Iraklis-Stavros PanagiotidisDepartment of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 1683, Cyprus.
Guillaume ZoppiFaculty of Engineering and Environment, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK.
Anna M BlackFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK.
Lynn G DoverFaculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK.
Leon BowenDepartment of Physics, G.J. Russell Microscopy Facility, Durham University, Durham, DH1 3LE, UK.
Ángel Serrano-ArocaBiomaterials and Bioengineering Lab, Department of Biotechnology, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, Valencia, 46001, Spain.
Lorenzo MendolaNanovea Inc, 6 Morgan Ste 156, Irvine, CA, 92618, USA.
Davide MorroneNanovea Inc, 6 Morgan Ste 156, Irvine, CA, 92618, USA.
Mihalis I PanayiotidisDepartment of Cancer Genetics, Therapeutics and Ultrastructural Pathology, The Cyprus Institute of Neurology and Genetics, Nicosia, 1683, Cyprus.
Martin BirkettFaculty of Engineering and Environment, Northumbria University, Newcastle upon Tyne, NE1 8ST, UK.ORCID 0000-0002-6135-6639

Funding

Engineering and Physical Sciences Research Council EPSRC-UKRI411Leverhulme Trust RPG-2018-344
6 · The paper itself

Abstract

Current biomedical implants have high mechanical strength and corrosion resistance, but are highly susceptible to wear and lack antimicrobial properties to fight infection. Here, nitrogen and oxygen-doped Ti

Indexed as

Coated Materials, BiocompatibleCopperProstheses and ImplantsTitaniumAlloysAnimalsAnti-Bacterial AgentsHumansMaterials TestingMiceNitrogenOxygenSurface PropertiesAlloysAnti-Bacterial AgentsCoated Materials, BiocompatibleCopperNitrogenOxygenTitaniumtitanium alloy (TiAl6V4)antimicrobialbiocompatiblehigh hardnessTi3Au thin film coatingwear resistant

Identifiers

PMID41165512
PMCPMC12892012

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.